Detection and diagnosis of prostate cancer: What's new

Vincenzo Scattoni, Mattia Sangalli, Marco Roscigno, Marco Raber, Andrea Gallina, Fabio Fabbri, Antonio Saccà, Andrea Salonia, Francesco Montorsi, Patrizio Rigatti

Research output: Contribution to journalArticle

6 Citations (Scopus)

Abstract

Objective: Prior the widespread use of PSA screening in asymptomatic men, prostate cancer was historically detected by a simple digital rectal examination. Although the gold standard for prostate cancer still remains prostate biopsy, current researches in the area of detection and diagnosis of prostate carcinoma are focusing on identification of better sampling protocols, biologic markers and imaging strategies in order to detect disease at an earlier stage. We reviewed all the recent literature on the detection of clinically meaningful prostate cancer. Methods: A systematic review of the literature using Medline up to 2005 was performed. Electronic searches were limited to the English language using the keywords prostate cancer, diagnosis, transrectal ultrasound, prostate biopsy. Unpublished information known by the authors and that were considered of interest to the readers were also included. Results: The prostate biopsy technique has extremely changed from the original Hodge's sextant biopsy protocol. Several authors have already reported high rates of false negative biopsy using sextant protocols. The optimal protocol should, nowadays, include six standard sextant biopsies with additional biopsies weighted more laterally (anterior horn) and medially to the apex. Repeat biopsies should also be based on an extended scheme and should include the transition zone especially in patient with at initial negative biopsy. To increase accuracy of prostatic biopsy and reduce unnecessary prostate biopsy, TRUS, power Doppler imaging (PDI), colour Doppler TRUS (CDUS), and 3-dimensional Doppler (3DD) can be successfully adopted, but their routine use is still controversial. Several types of local anaesthesia are now available and can be safely performed to reduce the pain of multi-sites biopsy protocol. Conclusion: Extended biopsy schemes should be performed not only at first biopsy but especially at repeated biopsy for premalignancy lesions. The widespread use of local anesthesia makes the procedure more comfortable.

Original languageEnglish
Pages (from-to)173-179
Number of pages7
JournalArchivio Italiano di Urologia e Andrologia
Volume77
Issue number3
Publication statusPublished - Sep 2005

Fingerprint

Prostatic Neoplasms
Biopsy
Prostate
Local Anesthesia
Digital Rectal Examination
Horns
Language
Color
Biomarkers
Carcinoma
Pain

Keywords

  • Diagnosis
  • Prostate biopsy
  • Prostate cancer
  • Transrectal ultrasound

ASJC Scopus subject areas

  • Nephrology
  • Urology

Cite this

Scattoni, V., Sangalli, M., Roscigno, M., Raber, M., Gallina, A., Fabbri, F., ... Rigatti, P. (2005). Detection and diagnosis of prostate cancer: What's new. Archivio Italiano di Urologia e Andrologia, 77(3), 173-179.

Detection and diagnosis of prostate cancer : What's new. / Scattoni, Vincenzo; Sangalli, Mattia; Roscigno, Marco; Raber, Marco; Gallina, Andrea; Fabbri, Fabio; Saccà, Antonio; Salonia, Andrea; Montorsi, Francesco; Rigatti, Patrizio.

In: Archivio Italiano di Urologia e Andrologia, Vol. 77, No. 3, 09.2005, p. 173-179.

Research output: Contribution to journalArticle

Scattoni, V, Sangalli, M, Roscigno, M, Raber, M, Gallina, A, Fabbri, F, Saccà, A, Salonia, A, Montorsi, F & Rigatti, P 2005, 'Detection and diagnosis of prostate cancer: What's new', Archivio Italiano di Urologia e Andrologia, vol. 77, no. 3, pp. 173-179.
Scattoni V, Sangalli M, Roscigno M, Raber M, Gallina A, Fabbri F et al. Detection and diagnosis of prostate cancer: What's new. Archivio Italiano di Urologia e Andrologia. 2005 Sep;77(3):173-179.
Scattoni, Vincenzo ; Sangalli, Mattia ; Roscigno, Marco ; Raber, Marco ; Gallina, Andrea ; Fabbri, Fabio ; Saccà, Antonio ; Salonia, Andrea ; Montorsi, Francesco ; Rigatti, Patrizio. / Detection and diagnosis of prostate cancer : What's new. In: Archivio Italiano di Urologia e Andrologia. 2005 ; Vol. 77, No. 3. pp. 173-179.
@article{2bb8d90b818248a19554e76b96cad6f5,
title = "Detection and diagnosis of prostate cancer: What's new",
abstract = "Objective: Prior the widespread use of PSA screening in asymptomatic men, prostate cancer was historically detected by a simple digital rectal examination. Although the gold standard for prostate cancer still remains prostate biopsy, current researches in the area of detection and diagnosis of prostate carcinoma are focusing on identification of better sampling protocols, biologic markers and imaging strategies in order to detect disease at an earlier stage. We reviewed all the recent literature on the detection of clinically meaningful prostate cancer. Methods: A systematic review of the literature using Medline up to 2005 was performed. Electronic searches were limited to the English language using the keywords prostate cancer, diagnosis, transrectal ultrasound, prostate biopsy. Unpublished information known by the authors and that were considered of interest to the readers were also included. Results: The prostate biopsy technique has extremely changed from the original Hodge's sextant biopsy protocol. Several authors have already reported high rates of false negative biopsy using sextant protocols. The optimal protocol should, nowadays, include six standard sextant biopsies with additional biopsies weighted more laterally (anterior horn) and medially to the apex. Repeat biopsies should also be based on an extended scheme and should include the transition zone especially in patient with at initial negative biopsy. To increase accuracy of prostatic biopsy and reduce unnecessary prostate biopsy, TRUS, power Doppler imaging (PDI), colour Doppler TRUS (CDUS), and 3-dimensional Doppler (3DD) can be successfully adopted, but their routine use is still controversial. Several types of local anaesthesia are now available and can be safely performed to reduce the pain of multi-sites biopsy protocol. Conclusion: Extended biopsy schemes should be performed not only at first biopsy but especially at repeated biopsy for premalignancy lesions. The widespread use of local anesthesia makes the procedure more comfortable.",
keywords = "Diagnosis, Prostate biopsy, Prostate cancer, Transrectal ultrasound",
author = "Vincenzo Scattoni and Mattia Sangalli and Marco Roscigno and Marco Raber and Andrea Gallina and Fabio Fabbri and Antonio Sacc{\`a} and Andrea Salonia and Francesco Montorsi and Patrizio Rigatti",
year = "2005",
month = "9",
language = "English",
volume = "77",
pages = "173--179",
journal = "Archivio Italiano di Urologia Nefrologia Andrologia",
issn = "1120-8538",
publisher = "Edizioni Scripta Manent s.n.c.",
number = "3",

}

TY - JOUR

T1 - Detection and diagnosis of prostate cancer

T2 - What's new

AU - Scattoni, Vincenzo

AU - Sangalli, Mattia

AU - Roscigno, Marco

AU - Raber, Marco

AU - Gallina, Andrea

AU - Fabbri, Fabio

AU - Saccà, Antonio

AU - Salonia, Andrea

AU - Montorsi, Francesco

AU - Rigatti, Patrizio

PY - 2005/9

Y1 - 2005/9

N2 - Objective: Prior the widespread use of PSA screening in asymptomatic men, prostate cancer was historically detected by a simple digital rectal examination. Although the gold standard for prostate cancer still remains prostate biopsy, current researches in the area of detection and diagnosis of prostate carcinoma are focusing on identification of better sampling protocols, biologic markers and imaging strategies in order to detect disease at an earlier stage. We reviewed all the recent literature on the detection of clinically meaningful prostate cancer. Methods: A systematic review of the literature using Medline up to 2005 was performed. Electronic searches were limited to the English language using the keywords prostate cancer, diagnosis, transrectal ultrasound, prostate biopsy. Unpublished information known by the authors and that were considered of interest to the readers were also included. Results: The prostate biopsy technique has extremely changed from the original Hodge's sextant biopsy protocol. Several authors have already reported high rates of false negative biopsy using sextant protocols. The optimal protocol should, nowadays, include six standard sextant biopsies with additional biopsies weighted more laterally (anterior horn) and medially to the apex. Repeat biopsies should also be based on an extended scheme and should include the transition zone especially in patient with at initial negative biopsy. To increase accuracy of prostatic biopsy and reduce unnecessary prostate biopsy, TRUS, power Doppler imaging (PDI), colour Doppler TRUS (CDUS), and 3-dimensional Doppler (3DD) can be successfully adopted, but their routine use is still controversial. Several types of local anaesthesia are now available and can be safely performed to reduce the pain of multi-sites biopsy protocol. Conclusion: Extended biopsy schemes should be performed not only at first biopsy but especially at repeated biopsy for premalignancy lesions. The widespread use of local anesthesia makes the procedure more comfortable.

AB - Objective: Prior the widespread use of PSA screening in asymptomatic men, prostate cancer was historically detected by a simple digital rectal examination. Although the gold standard for prostate cancer still remains prostate biopsy, current researches in the area of detection and diagnosis of prostate carcinoma are focusing on identification of better sampling protocols, biologic markers and imaging strategies in order to detect disease at an earlier stage. We reviewed all the recent literature on the detection of clinically meaningful prostate cancer. Methods: A systematic review of the literature using Medline up to 2005 was performed. Electronic searches were limited to the English language using the keywords prostate cancer, diagnosis, transrectal ultrasound, prostate biopsy. Unpublished information known by the authors and that were considered of interest to the readers were also included. Results: The prostate biopsy technique has extremely changed from the original Hodge's sextant biopsy protocol. Several authors have already reported high rates of false negative biopsy using sextant protocols. The optimal protocol should, nowadays, include six standard sextant biopsies with additional biopsies weighted more laterally (anterior horn) and medially to the apex. Repeat biopsies should also be based on an extended scheme and should include the transition zone especially in patient with at initial negative biopsy. To increase accuracy of prostatic biopsy and reduce unnecessary prostate biopsy, TRUS, power Doppler imaging (PDI), colour Doppler TRUS (CDUS), and 3-dimensional Doppler (3DD) can be successfully adopted, but their routine use is still controversial. Several types of local anaesthesia are now available and can be safely performed to reduce the pain of multi-sites biopsy protocol. Conclusion: Extended biopsy schemes should be performed not only at first biopsy but especially at repeated biopsy for premalignancy lesions. The widespread use of local anesthesia makes the procedure more comfortable.

KW - Diagnosis

KW - Prostate biopsy

KW - Prostate cancer

KW - Transrectal ultrasound

UR - http://www.scopus.com/inward/record.url?scp=28344450956&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=28344450956&partnerID=8YFLogxK

M3 - Article

C2 - 16372515

AN - SCOPUS:28344450956

VL - 77

SP - 173

EP - 179

JO - Archivio Italiano di Urologia Nefrologia Andrologia

JF - Archivio Italiano di Urologia Nefrologia Andrologia

SN - 1120-8538

IS - 3

ER -